Pharmacokinetic Drug Interactions
- 8 July 1986
- journal article
- research article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 26 (6) , 469-473
- https://doi.org/10.1002/j.1552-4604.1986.tb03560.x
Abstract
Drugs labeled with stable isotopes have been successfully used in pharmacokinetic drug interaction studies. This technique provides precise information on the mechanisms responsible for drug interactions, e.g., changes in clearance due to induction or inhibition of drug metabolism, bioavailability, and volume of distribution. It offers the advantage that detailed studies on the pharmacokinetics and metabolism of a drug can be conducted in a clinical setting during steady‐state conditions, thus avoiding problems in patient management that can arise from studies in which drug is withdrawn.Keywords
This publication has 14 references indexed in Scilit:
- Application of Stable Labelled Drugs in Clinical Pharmacokinetic InvestigationsClinical Pharmacokinetics, 1982
- Valproic acid disposition in epileptic patients during combined antiepileptic maintenance therapyEuropean Journal of Clinical Pharmacology, 1981
- Mechanism of valproate-phenobarbital interaction in epileptic patientsClinical Pharmacology & Therapeutics, 1981
- Interaction of secobarbital with warfarin pseudoracematesClinical Pharmacology & Therapeutics, 1980
- Stable Isotopes in Pharmacokinetic StudiesAnnual Review of Pharmacology and Toxicology, 1980
- Stereoselective Interaction of Phenylbutazone with [12C/13C]Warfarin Pseudoracemates in ManJournal of Clinical Investigation, 1980
- Single and chronic dose pharmacokinetic studies of sodium valproate in epileptic patientsEuropean Journal of Clinical Pharmacology, 1979
- Clinical Pharmacokinetics of CarbamazepineClinical Pharmacokinetics, 1978
- Plasma kinetics of carbamazepine and its epoxide metabolite in man after single and multiple dosesEuropean Journal of Clinical Pharmacology, 1975